Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children

Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children

ObjectiveTo evaluate the clinical efficacy and safety of a short course of blinatumomab in children with refractory or relapsed precursor B-cell acute lymphoblastic leukemia (R/R-BCP-ALL).MethodsThe clinical data of 33 R/R BCP-ALL children aged 0–18 years who underwent a short course of blinatumomab...

Full description

Bibliographic Details
Main Authors: Jiao Xie, Suxiang Liu, Ming Zhou, Yi Wang, Hailong He, Peifang Xiao, Shaoyan Hu, Jun Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pediatrics
Subjects:
short-course
blinatumomab
acute lymphoblastic leukemia
hematopoietic stem cell transplantation
children
refractory/relapse
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1187607/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2023.1187607/full

Similar Items